ABC | Volume 113, Nº4, Outubro 2019

Artigo Original Abolhasani et al. Níveis séricos de marcadores na predição de DAC Arq Bras Cardiol. 2019; 113(4):667-674 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 18. Chen C, Khismatullin DB. Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells. PloS One. 2015;10(3):e0123088. 19. Galkina E, Ley K. Immune and inflammatorymechanisms of atherosclerosis. Annu Rev Immunol. 2009;27:165-97. 20. Khaki-Khatibi F, Mahmoodi N, Abolhasani S, Gharebaba RP. Correlation of fibrinolysis marker of plasma plasminogen activator inhibitor type-1 and oxidative stress parameters in occurrence and progression of coronary artery disease. Bull Env Pharmacol Life Sci. 2014;3(7):27-33. 21. Khaki-Khatibi F, Gharebaba RP, Yaghoubi A, Farajzade A, Mahmoodi N, Abolhasani S. Relationship between serum levels of fibronectin, leptin and hs-CRP with extension of coronary artery disease. Bull Env Pharmacol Life Sci. 2014;3(7):40-6. 22. Singh RB, Mengi SA, Xu YJ, Arneja AS, Dhalla NS. Pathogenesis of atherosclerosis: amultifactorial process. Exp Clin Cardiol. 2002;7(1):40-53. 23. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol. 2003;91(3A):3A-6A. 24. NigamPK,NarainVS,ChandraN,PuriVK,SaranRK,DwivedSK,etal.Serum and platelet sialic acid in acutemyocardial infarction. Indian J Clin Biochem. 1995;10(2):106-9. 25. Dufourcq P, Louis H, Moreau C, Daret D, Boisseau M, Lamazière JMD, et al. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol. 1998;18(2):168-76. 26. Luo M, Ji Y, Luo Y, Li R, Fay WP, Wu J. Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin. J Thromb Haemost. 2017;15(12):2451-60. 27. CaoDJ,GuoYL,ColmanRW.Urokinase-typeplasminogenactivatorreceptor is involved inmediatingtheapoptoticeffectofcleavedhighmolecularweight kininogen in human endothelial cells. Circ Res. 2004;94(9):1227-34. 28. Forood A, Malekpour-Afshar R, Mahdavi A. Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease. Addict Health. 2014;6(3-4):119-26. 29. Båvenholm P, De Faire U, Landou C, Efendic S, Nilsson J, Wiman B, et al. Progression of coronary artery disease in youngmale post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. Eur Heart J. 1998;19(3):402-10. 30. Naya M, Tsukamoto T, Inubushi M, Morita K, Katoh C, Furumoto T, et al. Elevated plasma plasminogen activator inhibitor type-1 is an independent predictor of coronary microvascular dysfunction in hypertension. Circ J. 2007;71(3):348-53. 31. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21(5):844-8. 32. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103(15):1955-60. 33. Crook M, Lumb P, Andrews V, Swaminathan R. Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals. Clin Sci. 1998;95(1):53-7. 34. Serdar Z, Serdar A, Altin A, Eryilmaz U, Albayrak S. The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes. Acta Cardiol. 2007;62(4):373-80. 35. KnuimanMW,Watts GF, Divitini ML. Is sialic acid an independent risk factor for cardiovascular disease? A 17-year follow-up study in Busselton, Western Australia. Ann Epidemiol. 2004;14(9):627-32. 36. Ghodke SS, Padalkar RK, Bhagat SS. hs-CRP: A” golden marker” of inflammation and coronary artery disease. Int J Health Sci Res. 2012;2(6):42-6. 37. Sharma SB, Garg S, Veerwal A, Dwivedi S. hs-CRP and oxidative stress in young CADpatients: a pilot study Indian J Clin Biochem. 2008;23(4):334-6. 38. Mahajan N, Malik N, Bahl A, Sharma Y, Dhawan V. Correlation among soluble markers and severity of disease in non-diabetic subjects with pre- mature coronary artery disease. Mol Cell Biochem. 2009;330(1-2):201-9. 39. Arroyo-Espliguero R, Avanzas P, Cosín-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J. 2004;25(5):401-8. 674